IRF8 Regulates Acid Ceramidase Expression to Mediate Apoptosis and Suppresses Myelogeneous Leukemia
Authors:
- 13 April 2011
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 71 (8) , 2882-2891
Abstract
IFN regulatory factor 8 (IRF8) is a key transcription factor for myeloid cell differentiation and its expression is frequently lost in hematopoietic cells of human myeloid leukemia patients. IRF8-deficient mice exhibit uncontrolled clonal expansion of undifferentiated myeloid cells that can progress to a fatal blast crisis, thereby resembling human chronic myelogeneous leukemia (CML). Therefore, IRF8 is a myeloid leukemia suppressor. Whereas the understanding of IRF8 function in CML has recently improved, the molecular mechanisms underlying IRF8 function in CML are still largely unknown. In this study, we identified acid ceramidase (A-CDase) as a general transcription target of IRF8. We demonstrated that IRF8 expression is regulated by IRF8 promoter DNA methylation in myeloid leukemia cells. Restoration of IRF8 expression repressed A-CDase expression, resulting in C16 ceramide accumulation and increased sensitivity of CML cells to FasL-induced apoptosis. In myeloid cells derived from IRF8-deficient mice, A-CDase protein level was dramatically increased. Furthermore, we demonstrated that IRF8 directly binds to the A-CDase promoter. At the functional level, inhibition of A-CDase activity, silencing A-CDase expression, or application of exogenous C16 ceramide sensitized CML cells to FasL-induced apoptosis, whereas overexpression of A-CDase decreased CML cells' sensitivity to FasL-induced apoptosis. Consequently, restoration of IRF8 expression suppressed CML development in vivo at least partially through a Fas-dependent mechanism. In summary, our findings determine the mechanism of IRF8 downregulation in CML cells and they determine a primary pathway of resistance to Fas-mediated apoptosis and disease progression. Cancer Res; 71(8); 2882–91. ©2011 AACR.Keywords
This publication has 52 references indexed in Scilit:
- Activation of IL-27 p28 Gene Transcription by Interferon Regulatory Factor 8 in Cooperation with Interferon Regulatory Factor 1Journal of Biological Chemistry, 2010
- The Interferon Consensus Sequence Binding Protein (ICSBP/IRF8) Activates Transcription of the FANCF Gene during Myeloid DifferentiationJournal of Biological Chemistry, 2009
- Antiapoptotic roles of ceramide‐synthase‐6‐generated C 16 ‐ceramide via selective regulation of the ATF6/ CHOP arm of ER‐stress‐response pathwaysThe FASEB Journal, 2009
- IFN Regulatory Factor 8 Sensitizes Soft Tissue Sarcoma Cells to Death Receptor–Initiated Apoptosis via Repression of FLICE-like Protein ExpressionCancer Research, 2009
- DNA Methylation Represses IFN-γ–Induced and Signal Transducer and Activator of Transcription 1–Mediated IFN Regulatory Factor 8 Activation in Colon Carcinoma CellsMolecular Cancer Research, 2008
- QUMA: quantification tool for methylation analysisNucleic Acids Research, 2008
- Constitutive activation of SHP2 in mice cooperates with ICSBP deficiency to accelerate progression to acute myeloid leukemiaJournal of Clinical Investigation, 2008
- Novel analogs of d-e-MAPP and B13. Part 1: Synthesis and evaluation as potential anticancer agentsBioorganic & Medicinal Chemistry, 2008
- Novel analogs of d-e-MAPP and B13. Part 2: Signature effects on bioactive sphingolipidsBioorganic & Medicinal Chemistry, 2008
- Identification of 12/15-lipoxygenase as a suppressor of myeloproliferative diseaseJournal of Experimental Medicine, 2006